SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001104659-23-106147
Filing Date
2023-10-03
Accepted
2023-10-03 07:37:54
Documents
9

Document Format Files

Seq Description Document Type Size
1 SC14D9C tm2327397d2_sc14d9c.htm SC14D9C 45541
2 EXHIBIT 2.1 tm2327397d2_ex2-1.htm EX-2.1 529721
3 EXHIBIT 99.1 tm2327397d2_ex99-1.htm EX-99.1 88685
4 EXHIBIT 99.2 tm2327397d2_ex99-2.htm EX-99.2 91175
5 EXHIBIT 99.3 tm2327397d2_ex99-3.htm EX-99.3 90547
6 EXHIBIT 99.4 tm2327397d2_ex99-4.htm EX-99.4 22744
7 GRAPHIC tm2327397d2_ex99-4img001.jpg GRAPHIC 3915
8 GRAPHIC tm2327397d2_ex99-4img002.jpg GRAPHIC 10865
9 GRAPHIC tm2327397d2_ex99-4img003.jpg GRAPHIC 12161
  Complete submission text file 0001104659-23-106147.txt   907714
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Filed by) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Subject) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-91575 | Film No.: 231301564
SIC: 2834 Pharmaceutical Preparations